Skip to main content

JANE STREET GROUP, LLC

Position in SCYX — Scynexis Inc

CIK 1595888 NEW YORK, NY

Position in SCYX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$52,394
+$42,983 QoQ
Shares Held
57,138
+283.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 44 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in SCYX Over Time

Shares Held

Position Value (USD)

Derivatives in SCYX

reported options exposure · as of Mar 31, 2026
CallValue
$25,034
CallShares
27,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $181,878,118 across 41 Drug Manufacturers - Specialty & Generic names. SCYX ranks #39 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SCYX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $25,034 27,300
2026-03-31 $52,394 57,138
2025-12-31 $9,411 14,892
2025-06-30 $26,659 39,496
2024-12-31 $32,073 26,507
2024-06-30 $41,124 20,562
2024-03-31 $137,766 93,719
2023-06-30 $32,836 11,131
2023-03-31 $40,158 13,386
2022-09-30 $59,687 24,870
2022-06-30 $47,884 25,745
2020-12-31 $77,127 10,082